HPV vaccine may cut rate of cervical cancer ‘precursors’
Summary of story from Yahoo!News, dosage June 16, recipe 2011
A new study has shown that the introduction of a human papillomavirus (HPV) vaccination program in Australia led to a reduction of high-grade cervical abnormalities (or HGAs).
During the study researchers examined trends in these abnormalities, which are precursors to cervical cancer before and after the introduction of a national HPV vaccine program for all women aged 12 – 26 years in Victoria, Australia.
The incidence of high-grade abnormalities in girls aged 17 and younger who were screened fell by nearly 50 per cent, but there was no decline among older age groups.
The report was published in The Lancet this month, in which the study authors concluded: “This is the first report of a decrease in incidence of HGAs within three years after the implementation of a population-wide HPV vaccination program.”











